BioLife Solutions (BLFS) Competitors $25.97 +0.17 (+0.66%) As of 12:04 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BLFS vs. SLNO, TMDX, NVST, LIVN, WRBY, INSP, LQDA, PRCT, LMAT, and AORTShould you be buying BioLife Solutions stock or one of its competitors? The main competitors of BioLife Solutions include Soleno Therapeutics (SLNO), TransMedics Group (TMDX), Envista (NVST), LivaNova (LIVN), Warby Parker (WRBY), Inspire Medical Systems (INSP), Liquidia Technologies (LQDA), PROCEPT BioRobotics (PRCT), LeMaitre Vascular (LMAT), and Artivion (AORT). These companies are all part of the "medical equipment" industry. BioLife Solutions vs. Its Competitors Soleno Therapeutics TransMedics Group Envista LivaNova Warby Parker Inspire Medical Systems Liquidia Technologies PROCEPT BioRobotics LeMaitre Vascular Artivion Soleno Therapeutics (NASDAQ:SLNO) and BioLife Solutions (NASDAQ:BLFS) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, media sentiment, profitability, dividends, analyst recommendations, risk, valuation and institutional ownership. Do analysts recommend SLNO or BLFS? Soleno Therapeutics presently has a consensus price target of $115.09, indicating a potential upside of 132.95%. BioLife Solutions has a consensus price target of $31.29, indicating a potential upside of 20.47%. Given Soleno Therapeutics' higher possible upside, research analysts clearly believe Soleno Therapeutics is more favorable than BioLife Solutions.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Soleno Therapeutics 0 Sell rating(s) 0 Hold rating(s) 11 Buy rating(s) 1 Strong Buy rating(s) 3.08BioLife Solutions 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.13 Does the media refer more to SLNO or BLFS? In the previous week, Soleno Therapeutics had 25 more articles in the media than BioLife Solutions. MarketBeat recorded 36 mentions for Soleno Therapeutics and 11 mentions for BioLife Solutions. BioLife Solutions' average media sentiment score of 0.68 beat Soleno Therapeutics' score of 0.57 indicating that BioLife Solutions is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Soleno Therapeutics 7 Very Positive mention(s) 1 Positive mention(s) 13 Neutral mention(s) 2 Negative mention(s) 2 Very Negative mention(s) Positive BioLife Solutions 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, SLNO or BLFS? Soleno Therapeutics has a beta of -2.71, indicating that its stock price is 371% less volatile than the S&P 500. Comparatively, BioLife Solutions has a beta of 1.78, indicating that its stock price is 78% more volatile than the S&P 500. Which has preferable earnings & valuation, SLNO or BLFS? BioLife Solutions has higher revenue and earnings than Soleno Therapeutics. BioLife Solutions is trading at a lower price-to-earnings ratio than Soleno Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSoleno TherapeuticsN/AN/A-$175.85M-$4.14-11.93BioLife Solutions$82.25M15.12-$20.18M-$0.12-216.41 Is SLNO or BLFS more profitable? Soleno Therapeutics has a net margin of 0.00% compared to BioLife Solutions' net margin of -5.39%. BioLife Solutions' return on equity of 0.16% beat Soleno Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Soleno TherapeuticsN/A -73.74% -56.67% BioLife Solutions -5.39%0.16%0.14% Do institutionals and insiders believe in SLNO or BLFS? 97.4% of Soleno Therapeutics shares are held by institutional investors. Comparatively, 93.2% of BioLife Solutions shares are held by institutional investors. 6.4% of Soleno Therapeutics shares are held by insiders. Comparatively, 2.2% of BioLife Solutions shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. SummaryBioLife Solutions beats Soleno Therapeutics on 8 of the 15 factors compared between the two stocks. Get BioLife Solutions News Delivered to You Automatically Sign up to receive the latest news and ratings for BLFS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BLFS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BLFS vs. The Competition Export to ExcelMetricBioLife SolutionsMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.24B$10.49B$5.72B$10.26BDividend YieldN/A1.86%5.72%4.60%P/E Ratio-216.4820.6475.1026.36Price / Sales15.1229.80498.56167.32Price / Cash208.2225.0025.8129.90Price / Book3.453.4513.236.29Net Income-$20.18M$210.63M$3.28B$270.30M7 Day Performance-1.63%-1.15%0.32%1.95%1 Month Performance6.69%1.90%4.73%6.14%1 Year Performance2.00%-11.06%73.16%27.92% BioLife Solutions Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BLFSBioLife Solutions2.6427 of 5 stars$25.97+0.7%$31.29+20.5%+2.7%$1.24B$82.25M-216.48440News CoverageSLNOSoleno Therapeutics4.4332 of 5 stars$72.30+3.6%$115.09+59.2%-3.2%$3.71BN/A-17.4630Positive NewsShort Interest ↑TMDXTransMedics Group2.3926 of 5 stars$105.58+1.5%$122.11+15.7%-24.5%$3.55B$441.54M54.70210Analyst ForecastNVSTEnvista3.8252 of 5 stars$21.14-0.8%$20.92-1.0%+8.8%$3.54B$2.51B66.0512,300Positive NewsLIVNLivaNova3.0292 of 5 stars$58.32+0.6%$59.71+2.4%+14.2%$3.17B$1.25B-14.992,900Positive NewsWRBYWarby Parker1.5182 of 5 stars$26.74+2.8%$24.06-10.0%+80.0%$2.74B$771.32M-382.003,780Positive NewsAnalyst UpgradeInsider TradeINSPInspire Medical Systems4.9032 of 5 stars$83.51-3.4%$164.50+97.0%-60.3%$2.56B$802.80M48.271,246Positive NewsLQDALiquidia Technologies3.6574 of 5 stars$27.98-3.0%$32.11+14.8%+173.3%$2.48B$14M-16.4650PRCTPROCEPT BioRobotics3.1603 of 5 stars$38.92-4.3%$73.22+88.1%-53.2%$2.26B$224.50M-25.11430Positive NewsAnalyst ForecastLMATLeMaitre Vascular3.1789 of 5 stars$97.07-0.4%$97.60+0.5%+3.0%$2.21B$219.86M47.12490Positive NewsAORTArtivion2.881 of 5 stars$43.34-0.3%$40.63-6.2%+57.4%$2.05B$388.54M-103.191,600Positive News Related Companies and Tools Related Companies Soleno Therapeutics Competitors TransMedics Group Competitors Envista Competitors LivaNova Competitors Warby Parker Competitors Inspire Medical Systems Competitors Liquidia Technologies Competitors PROCEPT BioRobotics Competitors LeMaitre Vascular Competitors Artivion Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BLFS) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | SponsoredSean Hannity: Help Protect Your RetirementThis Guide to retirement protection has helped thousands protect over $3 billion dollars in retirement savings...Goldco Precious Metals | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredWhat a Former CIA Agent Knows About the Coming Collapse This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioLife Solutions, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioLife Solutions With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.